Pancreatic Cancer Research

ResearcherLeiden University Medical CenterActive in the last 2 years

Wilma E. Mesker

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-5533-4778; OpenAlex author ID A5084788672. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 8

  1. Protein N-Glycosylation Traits Combined with CA19-9 Accurately Distinguish Pancreatic Cancer Cases From Healthy Controls and Benign Pancreatic Diseases. Co-author DOI 10.1097/mpa.0000000000002517↗
  2. Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individuals. Last author DOI 10.1016/j.pan.2022.03.021↗
  3. Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. Co-author DOI 10.1016/j.thromres.2021.08.002↗
  4. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. Co-author DOI 10.3390/ijms22052655↗
  5. Serum N-Glycome analysis reveals pancreatic cancer disease signatures. Co-author DOI 10.1002/cam4.3439↗
  6. Application of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort. Co-author DOI 10.1016/j.tranon.2016.03.003↗
  7. Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques. Co-author DOI 10.1007/s00432-014-1812-2↗
  8. Detection of pancreatic cancer using serum protein profiling. Co-author DOI 10.1111/hpb.12017↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuri E. M. van der Burgt · 7 shared papers, 2013–2025 · strength 0.73
  2. Bert A. Bonsing · 7 shared papers, 2013–2022 · strength 0.63
  3. Rob A.E.M. Tollenaar · 7 shared papers, 2013–2022 · strength 0.63
  4. Manfred Wuhrer · 4 shared papers, 2020–2025 · strength 0.59
  5. Monique Esther van Leerdam · 3 shared papers, 2021–2025 · strength 0.49
  6. Randa G. Hanna-Sawires · 4 shared papers, 2020–2022 · strength 0.48
  7. Hans F. A. Vasen · 5 shared papers, 2013–2022 · strength 0.40
  8. Derk C.F. Klatte · 2 shared papers, 2022–2025 · strength 0.35
  9. Aleksander M. Bogdanski · 1 shared paper, 2025 · strength 0.23
  10. Jeanin Elise van Hooft · 1 shared paper, 2025 · strength 0.23
  11. Michael B. Wallace · 1 shared paper, 2025 · strength 0.23
  12. Yan Bi · 1 shared paper, 2025 · strength 0.23
  13. Gerda C. M. Vreeker · 2 shared papers, 2020–2022 · strength 0.22
  14. Jesse V. Groen · 1 shared paper, 2021 · strength 0.12
  15. J. Sven D. Mieog · 1 shared paper, 2021 · strength 0.12
  16. Alexander L. Vahrmeijer · 1 shared paper, 2021 · strength 0.12
  17. Brechtje D.M. Koopmann · 1 shared paper, 2022 · strength 0.12
  18. Iris J. M. Levink · 1 shared paper, 2022 · strength 0.12
  19. Isaura S. Ibrahim · 1 shared paper, 2022 · strength 0.12
  20. Kasper A. Overbeek · 1 shared paper, 2022 · strength 0.12
  21. Marco J. Bruno · 1 shared paper, 2022 · strength 0.12
  22. Djuna L. Cahen · 1 shared paper, 2022 · strength 0.12
  23. Gwenny Manel Fuhler · 1 shared paper, 2022 · strength 0.12
  24. Berit Velstra · 2 shared papers, 2013–2015 · strength 0.08
  25. Thomas P. Potjer · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.